Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Free Cash Flow Generation Index

Latest as of December 2024: -1.24x

Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Free Cash Flow Generation Index of -1.24x as of December 2024. Free cash flow of CN¥-58.25 Million represents -1% of operating cash flow (CN¥47.07 Million). Read debt load of Suzhou Fushilai Pharmaceutical Co. Ltd. for a breakdown of total debt and financial obligations.

FCF Generation Index

-1.24x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-58.25 Million
CNY

Operating Cash Flow

CN¥47.07 Million
CNY

Capital Expenditures

CN¥105.31 Million
CNY

Suzhou Fushilai Pharmaceutical Co. Ltd. Free Cash Flow Generation Index (2019–2024)

Historical FCF Generation Index trend for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Explore 301258 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)

Year-by-year Free Cash Flow Generation Index for Suzhou Fushilai Pharmaceutical Co. Ltd.. For the full company profile including market capitalisation, see Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) total market value.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 -1.24x CN¥-58.25 Million CN¥47.07 Million CN¥105.31 Million ▼ -320.7%
2023 0.56x CN¥53.15 Million CN¥94.77 Million CN¥41.62 Million ▼ -16.1%
2022 0.67x CN¥101.08 Million CN¥151.19 Million CN¥50.11 Million ▲ +12.2%
2021 0.60x CN¥118.98 Million CN¥199.73 Million CN¥80.75 Million ▼ -1.7%
2020 0.61x CN¥101.16 Million CN¥166.85 Million CN¥65.69 Million ▲ +14.6%
2019 0.53x CN¥79.62 Million CN¥150.55 Million CN¥70.93 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).